F-FDG PET and Tc-MDP Bone Scintigraphy in the Detection of Bony Metastasis from Medullary Thyroid Cancer: A Case Report
نویسندگان
چکیده
Received 7/23/2005; revised 7/29/2005; accepted 8/3/2005. For correspondence or reprints contact: Yeh-You Shen, M.D., Division of Nuclear Medicine, Shin Kong Wu Ho-Su Memorial Hospital. 95 Wen Chang Road., Shih Lin District, Taipei 111, Taiwan. Tel: (886)2-28332211 ext. 2280, Fax: (886)2-28389489, E-mail: [email protected] A 52-year-old man with history of medullary thyroid cancer (MTC) received total thyroidectomy and left neck lymph node dissection six years ago and then received wide excision for right chest wall metastases one month later. After operation, he received Tc-MDP bone scintigraphy and F-fluorodeoxyglucose positron emission tomography (FDG PET) for follow up. The bone scintigraphy revealed only a limited number of metastatic bony lesions. However, in contrast with bone scintigraphy, FDG PET showed wide-spread multiple metastatic bony lesions, much more than that shown by bone scintigraphy. The difference of imaging mechanism and morphologic characteristics of bony metastasis from MTC might attribute to the discrepancy in diagnostic sensitivity in MTC with bone metastasis between FDG PET and bone scintigraphy. As compared with bone scintigraphy, FDG-PET scan showed higher sensitivity for the detection of bony metastasis from medullary thyroid cancer.
منابع مشابه
Detection of solitary bone metastasis by 99mTc-octreotide scintigraphy in a patient with Hurthle cell carcinoma: A case report
A 75-year-old male patient with non-avid radioiodine Hurthle cell carcinoma was evaluated by 99m Tc- octreotide scintigraphy, in order to find possible metastatic lesions. A bony metastatic lesion was detected by this procedure which was confirmed by histopathology.99mTc-octreotide scintigraphy is a precise and cost-effective imaging modality for detection of non-iodine av...
متن کاملUtility of F-18 FDG PET/CT for Detection of Bone Marrow Metastases in Prostate Cancer Patients Treated with Radium-223
A 76-year-old man with symptomatic bone metastases from castrationresistant prostate cancer underwent Radium-223-dichloride (Ra-223) therapy. Before Ra-223 therapy, he had normal peripheral blood cell counts. Ra-223 therapy relieved his shoulder and low back pain. The elevation of the serum prostate-specific antigen (PSA), doubling every month during Ra-223 therapy, suggested a PSA flare or rel...
متن کاملComparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas.
BACKGROUND Positron emission tomography (PET) with 18-F-fluorodeoxyglucose (FDG) has already proved useful in assessing the extension of esophageal carcinomas, detecting tumor recurrence and monitoring responses to therapy. This study aimed to elucidate the potential role of FDG-PET compared with technetium-99m methylene diphosphonate (Tc-99m MDP) bone scintigraphy in the evaluation of bony met...
متن کاملDiscordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
OBJECTIVE At present, metastatic bone involvement is usually assessed using bone scintigraphy, which has a high sensitivity but a poor specificity. The objective of our study was to compare the sensibility of the 2-deoxy-2-[18F] fluoro-d-glucose positron emission tomography/computed tomography (F-18 FDG PET/CT) for the detection of bone metastasis in patients with non-small-cell lung cancer (NS...
متن کاملIs (99m)Tc-MDP whole body bone scintigraphy adjuvant to (18)F-FDG-PET for the detection of skeletal metastases?
PURPOSE Due to the fact that fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography ((18)F-FDG-PET/CT) and technetium-99m-methylenediphosphonate ((99m)Tc-MDP) whole body scans identify bone metastases by different mechanisms, i.e. by using glucose metabolism and osteoblastic response in the bone, respectively, it can be expected that there may be some differences betwee...
متن کامل